Infusol NS Sodium Chloride 0.9% IV Infusion

Infusol NS is a sterile, single-use intravenous (IV) infusion fluid containing Sodium Chloride 0.9% w/v (isotonic “normal saline”) in water for injection, manufactured in Malaysia by Ain Medicare Sdn Bhd to British Pharmacopoeia (BP) standards under the INFUSOL brand. It is supplied as a clear, colourless, particle-free solution in a flexible 500ml infusion bag intended solely for intravenous administration, never for oral or topical use.

Infusol NS belongs to the large-volume parenteral (IV fluid) class of pharmaceutical products, distinct from oral medicines or topical preparations. It is one strength within the wider INFUSOL range from Ain Medicare, which also includes Sodium Chloride 0.45% (Infusol HS), Sodium Chloride 3% (Infusol S3), and various dextrose and dextrose-saline combination infusions; Infusol NS specifically refers to the isotonic 0.9% w/v sodium chloride formulation.

Because this is an IV infusion fluid, it is manufactured, packaged, and sterilised for administration by trained healthcare professionals using sterile equipment and aseptic technique, rather than for self-administration by consumers at home. It is available in a 500ml infusion bag as the standard pack size supplied to clinics, hospitals, and healthcare providers, and through pharmacies that supply such professional-use products.

Infusol NS is administered intravenously by a healthcare professional (doctor, nurse, or trained clinical staff) using a sterile giving set and aseptic technique, typically via a peripheral or central venous line. The infusion bag is inspected for clarity, absence of leaks or particulate matter, and an intact tamper-evident seal before use, and is connected using sterile, single-use administration equipment. The rate and total volume of the infusion are set and monitored by the administering healthcare professional based on the patient’s individual fluid and electrolyte status, and the solution is not intended for consumers to prepare or administer themselves at home.

Infusol NS is not a product with a fixed consumer self-dosing schedule, as it is administered intravenously by a healthcare professional who determines the appropriate volume and infusion rate for each patient. In general clinical practice, IV normal saline infusions may range from around 500ml to 1000ml or more per session, but the exact volume, concentration adjustments (if combined with other additives), and rate are individualised by the treating doctor or nurse according to the patient’s condition, age, weight, and fluid/electrolyte needs. There is no consumer “missed dose” concept for this product. If you have been referred for or are considering IV fluid therapy, this should only take place under the direct guidance of a healthcare professional in an appropriate clinical setting — please do not attempt to self-administer this product, and speak to a doctor or pharmacist if you have any questions about whether IV fluid therapy is appropriate for you.

Use Infusol NS before the expiry date printed on the infusion bag and outer carton. Once the infusion bag has been opened or spiked for use, it is intended for single use only — any unused portion of an opened bag must be discarded and never reused for a later infusion or on a different patient.

Store below 30°C, away from direct sunlight and excessive heat, and keep the infusion bag in its original outer packaging until it is ready to be used by a healthcare professional. Do not use the solution if the bag is damaged, punctured, or leaking, if the tamper-evident seal has been broken, or if the solution is not clear and colourless or contains visible particles. Keep out of reach of children, and note that this product is not intended for home storage as a self-injectable item.

• Common: Mild discomfort, redness, or swelling at the intravenous cannula insertion site, which is usually managed by the administering healthcare team.
• Common: A cool sensation at the infusion site as the fluid enters the vein.
• Serious: Signs of fluid overload, such as swelling of the ankles or legs, shortness of breath, or a rapid increase in weight, particularly if the infusion is given too quickly or in patients with heart, kidney, or liver conditions — this is monitored for by the administering healthcare professional.
• Serious: Signs of infusion-site infection or phlebitis, such as warmth, pus, marked pain, or fever, which require prompt medical attention.
• Serious: Electrolyte imbalance (such as elevated sodium levels) if the infusion is used inappropriately or in excessive volumes without proper monitoring.

• Known hypersensitivity to sodium chloride or any component of the solution.
• Conditions involving fluid overload or retention, such as decompensated heart failure, unless specifically directed and closely monitored by a physician.
• Hypernatremia (elevated blood sodium levels), unless the infusion is specifically being used under medical supervision to correct a different imbalance.
• Situations where the patient’s clinical condition requires sodium or fluid restriction, unless a doctor has determined that IV normal saline is still appropriate.

• Infusol NS is often used as a carrier or diluent fluid for other injectable medicines given intravenously; compatibility of any added medicine with normal saline should always be confirmed by the healthcare professional before mixing, as not all drugs are compatible with sodium chloride solutions.
• Concurrent use of corticosteroids or other medicines that promote sodium and fluid retention may increase the risk of fluid overload when combined with IV normal saline, and requires closer monitoring by the healthcare team.
• As this is an intravenous product and not taken orally, no food interactions apply.

• Infusol NS is only for use by, or under the direct supervision of, a qualified healthcare professional in a clinical setting.
• Before administration, the infusion bag should be checked for clarity, absence of leaks or particulate matter, and an intact seal.
• Always confirm the expiry date printed on the bag and carton before use.
• A new, sterile single-use giving set should be used for each infusion.
• Any unused solution remaining in an opened bag should be discarded rather than stored for later use.
• Store within the recommended temperature range and keep out of reach of children when not in clinical use.

Precautions: Infusol NS must only be administered by a qualified healthcare professional who can assess the appropriate volume, rate, and any additives needed for each patient, particularly in pregnant or breastfeeding women, children, the elderly, and individuals with heart, kidney, or liver conditions, where fluid balance requires closer monitoring. It should not be self-administered under any circumstances.

When to See a Doctor or Pharmacist: If IV fluid therapy has been recommended or referred to you, discuss the specific details, setting, and monitoring plan with your doctor or pharmacist beforehand. If you notice any signs of an adverse reaction during or after an infusion, such as swelling, breathing difficulty, or pain and redness at the infusion site, seek medical attention promptly.